Department of Psychology, Faculty of Human Sciences, Macquarie University, Sydney, NSW, Australia.
School of Psychology, Faculty of Sciences, The University of Sydney, Sydney, NSW, Australia.
Psychopharmacology (Berl). 2022 Sep;239(9):2903-2919. doi: 10.1007/s00213-022-06175-9. Epub 2022 Aug 3.
Methamphetamine (METH, "ice") is a potent and addictive psychostimulant. Abuse of METH perturbs neurotransmitter systems and induces neurotoxicity; however, the neurobiological mechanisms which underlie addiction to METH are not fully understood, limiting the efficacy of available treatments. Here we investigate METH-induced changes to neuronal nitric oxide synthase (nNOS), parvalbumin and calretinin-expressing GABAergic interneuron populations within the nucleus accumbens (NAc), prefrontal cortex (PFC) and orbitofrontal cortex (OFC). We hypothesise that dysfunction or loss of these GABAergic interneuron populations may disrupt the excitatory/inhibitory balance within the brain.
Male Long Evans rats (N = 32) were trained to lever press for intravenous METH or received yoked saline infusions. Following 14 days of behavioural extinction, animals were given a non-contingent injection of saline or METH (1 mg/kg, IP) to examine drug-primed reinstatement to METH-seeking behaviours. Ninety minutes post-IP injection, animals were culled and brain sections were analysed for Fos, nNOS, parvalbumin and calretinin immunoreactivity in eight distinct subregions of the NAc, PFC and OFC.
METH exposure differentially affected GABAergic populations, with METH self-administration increasing nNOS immunoreactivity at distinct locations in the prelimbic cortex and decreasing parvalbumin immunoreactivity in the NAc. METH self-administration triggered reduced calretinin immunoreactivity, whilst acute METH administration produced a significant increase in calretinin immunoreactivity. As expected, non-contingent METH-priming treatment increased Fos immunoreactivity in subregions of the NAc and PFC.
Here we report that METH exposure in this model may alter the function of GABAergic interneurons in more subtle ways, such as alterations in neuronal firing or synaptic connectivity.
甲基苯丙胺(METH,“冰”)是一种强效且成瘾的精神兴奋剂。滥用 METH 会扰乱神经递质系统并诱导神经毒性;然而,导致对 METH 成瘾的神经生物学机制尚未完全阐明,这限制了现有治疗方法的疗效。在这里,我们研究了甲基苯丙胺对伏隔核(NAc)、前额叶皮层(PFC)和眶额皮层(OFC)中神经元型一氧化氮合酶(nNOS)、钙结合蛋白 Parvalbumin 和 Calretinin 表达的 GABA 能中间神经元群体的影响。我们假设这些 GABA 能中间神经元群体的功能障碍或丧失可能会破坏大脑内的兴奋/抑制平衡。
雄性长爪沙鼠(N=32)被训练用于按压杠杆以获得静脉内 METH 或接受配对的盐水输注。在 14 天的行为消退后,动物接受非条件性盐水或 METH(1mg/kg,IP)注射,以检查药物引发的对 METH 寻求行为的复燃。IP 注射后 90 分钟,处死动物并分析 NAc、PFC 和 OFC 八个不同亚区的 Fos、nNOS、Parvalbumin 和 Calretinin 免疫反应。
METH 暴露以不同的方式影响 GABA 能群体,METH 自我给药增加了前扣带皮层中不同位置的 nNOS 免疫反应,并降低了 NAc 中的 Parvalbumin 免疫反应。METH 自我给药导致 Calretinin 免疫反应减少,而急性 METH 给药导致 Calretinin 免疫反应显著增加。正如预期的那样,非条件性 METH 引发处理增加了 NAc 和 PFC 亚区的 Fos 免疫反应。
在这里,我们报告在该模型中,METH 暴露可能以更微妙的方式改变 GABA 能中间神经元的功能,例如神经元放电或突触连接的改变。